Literature DB >> 19471005

Subconjunctival ranibizumab for squamous cell carcinoma of the conjunctiva with corneal extension.

C C Teng, K J Chin, P T Finger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19471005     DOI： 10.1136/bjo.2008.156489

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Topical Bevacizumab for the Treatment of Ocular Surface Squamous Neoplasia.

Authors:  Leyla Asena; Dilek Dursun Altınörs
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-26       Impact factor: 2.671

2.  Topical ranibizumab as a treatment of corneal neovascularization.

Authors:  Giulio Ferrari; Mohammad H Dastjerdi; Andre Okanobo; Sheng-Fu Cheng; Francisco Amparo; Nambi Nallasamy; Reza Dana
Journal:  Cornea       Date:  2013-07       Impact factor: 2.651

3.  Diagnosis and Medical Management of Ocular Surface Squamous Neoplasia.

Authors:  Ibrahim O Sayed-Ahmed; Sotiria Palioura; Anat Galor; Carol L Karp
Journal:  Expert Rev Ophthalmol       Date:  2016-12-05

4.  Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?

Authors:  Sonal S Chaugule; Jennifer Park; Paul T Finger
Journal:  Indian J Ophthalmol       Date:  2018-01       Impact factor: 1.848

5.  Topical pharmacotherapy for ocular surface squamous neoplasia: systematic review and meta-analysis.

Authors:  Kincső Kozma; Zsuzsa Réka Dömötör; Adrienne Csutak; László Szabó; Péter Hegyi; Bálint Erőss; Zsuzsanna Helyes; Zsolt Molnár; Fanni Dembrovszky; Eszter Szalai
Journal:  Sci Rep       Date:  2022-08-20       Impact factor: 4.996
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.